Optimized anti-tuberculosis duration for drug-susceptible pulmonary tuberculosis-diabetes mellitus comorbidities: study protocol for a multicenter randomized controlled trial

被引：0
|
作者：
Peize Zhang [1 ]
Huaifang Shi [2 ]
Yongping Xie [3 ]
Jiemei Liang [3 ]
Qiumeng Hu [4 ]
Liang Fu [1 ]
Yuxiang Wang [5 ]
Jie Tan [1 ]
Senlin Zhan [1 ]
Hongjuan Qin [1 ]
Guanghui Xu [1 ]
Guofang Deng [1 ]
机构：
[1] Third People’s Hospital of Shenzhen,Department of Pulmonary Medicine and Tuberculosis
[2] Shenzhen Clinical Research Center for Tuberculosis,School of Public Health
[3] Shenzhen University Medical School,undefined
[4] Shenzhen University,undefined
[5] Jiangmen Institute of Tuberculosis Prevention and Control,undefined
[6] Shenzhen University Medical School,undefined
[7] Shenzhen University,undefined
来源：
BMC Pulmonary Medicine | / 24卷 / 1期
关键词：
Drug-susceptible pulmonary tuberculosis (PTB); Type 2 diabetes(DM); Treatment duration; Unfavorable outcome; Treatment success;
D O I：
10.1186/s12890-024-03271-8
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 47 条
  • [31] Evaluation of acute effect of light-emitting diode (LED) phototherapy on muscle deoxygenation and pulmonary oxygen uptake kinetics in patients with diabetes mellitus: study protocol for a randomized controlled trial
    Francisco, Cristina de Oliveira
    Beltrame, Thomas
    Ferraresi, Cleber
    Parizotto, Nivaldo Antonio
    Bagnato, Vanderlei Salvador
    Silva, Audrey Borghi
    Benze, Benedito Galvao
    Porta, Alberto
    Catai, Aparecida Maria
    TRIALS, 2015, 16
  • [32] Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial
    Akram, Javed
    Azhar, Shehnoor
    Shahzad, Muhammad
    Latif, Waqas
    Khan, Khalid Saeed
    TRIALS, 2020, 21 (01)
  • [33] Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial
    Javed Akram
    Shehnoor Azhar
    Muhammad Shahzad
    Waqas Latif
    Khalid Saeed Khan
    Trials, 21
  • [34] Efficacy of vitamin D3 supplementation in reducing incidence of pulmonary tuberculosis and mortality among HIV-infected Tanzanian adults initiating antiretroviral therapy: study protocol for a randomized controlled trial
    Sudfeld, Christopher R.
    Mugusi, Ferdinand
    Aboud, Said
    Nagu, Tumaini J.
    Wang, Molin
    Fawzi, Wafaie W.
    TRIALS, 2017, 18
  • [35] Efficacy of vitamin D3 supplementation in reducing incidence of pulmonary tuberculosis and mortality among HIV-infected Tanzanian adults initiating antiretroviral therapy: study protocol for a randomized controlled trial
    Christopher R. Sudfeld
    Ferdinand Mugusi
    Said Aboud
    Tumaini J. Nagu
    Molin Wang
    Wafaie W. Fawzi
    Trials, 18
  • [36] The Effect of acetyl-L-carnitine, Alpha-lipoic Acid, and Coenzyme Q10 Combination in Preventing Anti-tuberculosis Drug-induced Hepatotoxicity: A Randomized, Double-blind, Placebo-controlled Clinical Trial
    Hakimizad, Reza
    Soltani, Rasool
    Khorvash, Farzin
    Marjani, Majid
    Dastan, Farzaneh
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (03): : 431 - 440
  • [37] Efficacy and Safety of a 4-Drug Fixed-Dose Combination Regimen Compared With Separate Drugs for Treatment of Pulmonary Tuberculosis: The Study C Randomized Controlled Trial (vol 305, pg 1415, 2011)
    Lienhardt, Christian
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (12): : 1327 - 1327
  • [38] The efficacy and safety study of dietary supplement PURIAM110 on non-insulin taking Korean adults in the stage of pre-diabetes and diabetes mellitus: protocol for a randomized, double-blind, placebo-controlled, and multicenter trial-pilot study
    Park, Sunju
    Park, Jeong-Su
    Go, Hoyeon
    Jang, Bo-Hyoung
    Shin, Yongcheol
    Ko, Seong-Gyu
    TRIALS, 2011, 12
  • [39] The efficacy and safety study of dietary supplement PURIAM110 on non-insulin taking Korean adults in the stage of pre-diabetes and diabetes mellitus: protocol for a randomized, double-blind, placebo-controlled, and multicenter trial-pilot study
    Sunju Park
    Jeong-Su Park
    Hoyeon Go
    Bo-Hyoung Jang
    Yongcheol Shin
    Seong-Gyu Ko
    Trials, 12
  • [40] Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trial
    Ross, Jesse
    Perumal, Rubeshan
    Wolf, Allison
    Zulu, Mbali
    Guzman, Kevin
    Seepamore, Boitumelo
    Reis, Karl
    Nyilana, Hlengiwe
    Hlathi, Senzo
    Narasimmulu, Radhamoney
    Cheung, Ying Kuen K.
    Amico, K. Rivet
    Friedland, Gerald
    Daftary, Amrita
    Zelnick, Jennifer R.
    Naidoo, Kogieleum
    O'Donnell, Max R.
    TRIALS, 2023, 24 (01)
12345